PDCT-12. A PHASE I TRIAL OF TUMOR TREATING FIELDS WITH AND WITHOUT CONCOMITANT TEMOZOLOMIDE AND BEVACIZUMAB IN PEDIATRIC PATIENTS WITH HIGH-GRADE GLIOMA AND EPENDYMOMA | Zendy

AI Assistant Blog Pricing

PDCT-12. A PHASE I TRIAL OF TUMOR TREATING FIELDS WITH AND WITHOUT CONCOMITANT TEMOZOLOMIDE AND BEVACIZUMAB IN PEDIATRIC PATIENTS WITH HIGH-GRADE GLIOMA AND EPENDYMOMA

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.